What does a year of waiting mean for your joint?

What helps while you wait?

Short sessions of walking or strength work are easier to repeat than one hard workout. A physical therapist can change any exercise that leaves you much more sore.

Split a large chore across the day, change position before stiffness builds, and rest after harder work. Your doctor can review medicines that may be safe for you.

Once a week, note how you sleep, walk, and manage steps. These details show whether you are holding steady or finding ordinary tasks harder.

When is waiting no longer sensible?

An exam is due when the ache cuts short walks, wakes you, or stops basic chores. At QC Kinetix, regenerative treatments are procedures that prepare material taken from you and put it inside the joint.

A medical provider, the clinic's title for a licensed examiner, discusses those choices after checking you. That person isn't always a doctor. Ask who will examine you and who will perform any procedure.

Fever with one warm, swollen joint may mean infection. If an injury suddenly leaves you unable to stand on that leg, seek prompt care. New weakness, numbness, or loss of bladder or bowel control cannot wait.

How often can treatment be repeated?

There isn't one repeat schedule for every procedure. Timing depends on the material used, how you respond, and what the next exam shows.

Before repeating care, compare the same activity you tracked at the start. Ask about the full price and the expected rest afterward. More treatment doesn't always bring more help.

Another wait may be reasonable if the joint remains safe and useful. Arrange a new exam when you can walk less, move less, or manage fewer chores despite care.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. Global Burden of Disease data show osteoarthritis age-standardised prevalence rose 9.3 percent between 1990 and 2017 and years lived with disability rose 9.6 percent, with prevalence higher in women and rising with age.

   Safiri S, et al. — Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis, 2020. DOI: 10.1136/annrheumdis-2019-216515.

3. A systematic review of 21 studies re-examining the familiar '20 percent are dissatisfied after knee replacement' figure found the actual average dissatisfaction rate was 10 percent, and 7.3 percent when complications were excluded - the surgical benchmark a cash-pay injection is implicitly competing against.

   DeFrance MJ, et al. — Are 20% of Patients Actually Dissatisfied Following Total Knee Arthroplasty? A Systematic Review of the Literature. J Arthroplasty, 2023. DOI: 10.1016/j.arth.2022.10.011.

4. The AAOS Surgical Management of Osteoarthritis of the Knee clinical practice guideline sets out 16 recommendations and seven options for surgical management based on a systematic review of the published evidence - the reference point for when a joint has moved past the injectable tier.

   Srivastava AK, et al. — American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary of Surgical Management of Osteoarthritis of the Knee. J Am Acad Orthop Surg, 2023. DOI: 10.5435/JAAOS-D-23-00338.

5. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.